Srikanth Venkatraman

Srikanth Venkatraman is the Senior Vice President and Head of Chemistry, with a distinguished career spanning over two decades in medicinal chemistry and drug discovery. His expertise is particularly noted in the design of novel protease inhibitors. Venkatraman’s significant contributions include his role as a co-inventor of the first generation HCV protease inhibitors, Victrelis and Arlansa, during his tenure at Schering Plough, which later became part of Merck. His work has been recognized with the prestigious Heroes of Chemistry award by the American Chemical Society. Venkatraman completed his doctoral studies at the University of Pittsburgh and further honed his skills with postdoctoral training at the University of Illinois at Urbana Champaign.